| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 6,395,334 | 5,944,001 | 5,129,401 | | Cost of Revenue | 2,459,788 | 1,808,549 | 1,600,949 | | | Gross Profit | 3,935,547 | 4,135,453 | 3,528,452 | | | Operating Expenses | | Research Development |
-
| 673 | 865 | | Selling General and Administrative | 597,842 | 377,980 | 310,162 | | Non Recurring |
-
|
-
|
-
| | Others | 1,106,958 | 1,111,577 | 1,058,909 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,230,748 | 2,645,223 | 2,158,515 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (25,959) | (62,433) | 326,879 | | Earnings Before Interest And Taxes | 2,204,788 | 2,703,182 | 2,320,603 | | Interest Expense | 156,931 | 143,617 | 121,242 | | Income Before Tax | 2,047,857 | 2,559,565 | 2,199,361 | | Income Tax Expense | 568,065 | 760,094 | 755,857 | | Minority Interest | (394,416) | (483,155) | (396,466) | | | | Net Income From Continuing Ops | 1,087,422 | 1,196,556 | 1,211,145 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,087,422 | 1,196,556 | 1,211,145 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,087,422 | $1,196,556 | $1,211,145 |
|
0.51% Nasdaq 
Income Statement
